This site requires JavaScript to render the code.

Need to know how to enable JavaScript? Go here.

News
FAM19A4/miR124-2 methylation shows higher sensitivity than cytology for detection of CIN3+ in women living with HIV
October 2019, HPV-Risk assay clinically validated on SurePath cervical screening samples
December 2018, Self-screen and Novosanis received a prestigious Eurostar grant
February 2019, Results from an international study confirm the robustness of the QIAsure Methylation Test
November 2018, QIAGEN launches Self-screens HPV-Risk Assay as the QIAscreen HPV PCR Test
September 2018, Self-screen successfully passed the transition to the ISO13485:2016 standard